PL2702060T3 - Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczne - Google Patents
Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczneInfo
- Publication number
- PL2702060T3 PL2702060T3 PL12723913T PL12723913T PL2702060T3 PL 2702060 T3 PL2702060 T3 PL 2702060T3 PL 12723913 T PL12723913 T PL 12723913T PL 12723913 T PL12723913 T PL 12723913T PL 2702060 T3 PL2702060 T3 PL 2702060T3
- Authority
- PL
- Poland
- Prior art keywords
- risperidone
- pharmaceutical compositions
- acid addition
- addition salts
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN1310MU2011 | 2011-04-26 | ||
| EP12723913.5A EP2702060B1 (en) | 2011-04-26 | 2012-04-25 | Acid addition salts of risperidone and pharmaceutical compositions thereof |
| PCT/IB2012/052065 WO2012147035A1 (en) | 2011-04-26 | 2012-04-25 | Acid addition salts of risperidone and pharmaceutical compositions thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2702060T3 true PL2702060T3 (pl) | 2016-06-30 |
Family
ID=46172816
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL12723913T PL2702060T3 (pl) | 2011-04-26 | 2012-04-25 | Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczne |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US9040695B2 (pl) |
| EP (1) | EP2702060B1 (pl) |
| ES (1) | ES2564973T3 (pl) |
| HU (1) | HUE028159T2 (pl) |
| PL (1) | PL2702060T3 (pl) |
| WO (1) | WO2012147035A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2885941A1 (en) | 2012-09-28 | 2014-04-03 | Delpor, Inc. | Device and method for sustained release of antipsychotic medications |
| FR3020810B1 (fr) * | 2014-05-06 | 2016-05-06 | Servier Lab | Nouveau sel de l'ivabradine et son procede de preparation. |
| CN105481854B (zh) * | 2015-12-08 | 2017-11-10 | 天津市亨必达化学合成物有限公司 | 一种利培酮晶ⅲ型物质的制备方法 |
| RU2646812C1 (ru) * | 2016-10-24 | 2018-03-07 | Общество с ограниченной ответственностью "Трейдсервис" | Жидкая лекарственная форма рисперидона и способ ее получения |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4804663A (en) | 1985-03-27 | 1989-02-14 | Janssen Pharmaceutica N.V. | 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| EP0569096A1 (en) | 1992-05-08 | 1993-11-10 | Akzo Nobel N.V. | Depot preparation |
| TW376319B (en) | 1993-04-28 | 1999-12-11 | Janssen Pharmaceutica Nv | Pharmaceutical composition containing risperidone pamoate and having a long acting activity for treating psychoses induced by the release of dopamine |
| WO2004094414A1 (en) | 2003-04-22 | 2004-11-04 | Synthon B.V. | Water soluble salts of risperidone |
-
2012
- 2012-04-25 WO PCT/IB2012/052065 patent/WO2012147035A1/en active Application Filing
- 2012-04-25 PL PL12723913T patent/PL2702060T3/pl unknown
- 2012-04-25 US US14/114,379 patent/US9040695B2/en not_active Expired - Fee Related
- 2012-04-25 EP EP12723913.5A patent/EP2702060B1/en not_active Not-in-force
- 2012-04-25 HU HUE12723913A patent/HUE028159T2/en unknown
- 2012-04-25 ES ES12723913.5T patent/ES2564973T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HUE028159T2 (en) | 2016-12-28 |
| WO2012147035A1 (en) | 2012-11-01 |
| EP2702060A1 (en) | 2014-03-05 |
| US20140045864A1 (en) | 2014-02-13 |
| EP2702060B1 (en) | 2015-12-30 |
| US9040695B2 (en) | 2015-05-26 |
| ES2564973T3 (es) | 2016-03-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL254839B (en) | Derivatives of piperidine-4- and -2-carboxylic acids, perhydroazepine-4-carboxylic acid and (piperidin-4-yl)-acetic acid and pharmaceutical compositions comprising them | |
| IL233756A (en) | History of hydroxamic acid and their pharmaceutical preparations | |
| EP2797600A4 (en) | IMPROVED COMPOSITIONS AND METHODS OF DISTRIBUTING OMEPRAZOLE AND ACETYL SALICYLIC ACID | |
| IL230010B (en) | Inhalable pharmaceutical ingredients | |
| ZA201401027B (en) | Formulations of deoxycholic acid and salts thereof | |
| IL250370A0 (en) | Propionic acid derivatives substituted with heteroaroylamino in position 3 and their use as pharmaceuticals | |
| IL249825A0 (en) | Propionic acid derivatives converted in 3-heteroylamino and their use in pharmaceutical preparations | |
| SI2691083T1 (sl) | Farmacevtski sestavek sitagliptina | |
| HK1169379A1 (en) | Salts of 3-pentylphenylacetic acid and pharmaceutical uses thereof 3- | |
| HRP20180567T1 (hr) | Farmaceutski pripravak omeprazola | |
| HK1187335A1 (en) | Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals 3-- | |
| EP2888260A4 (en) | SUBSTITUTED AZAINDOLE COMPOUNDS, THEIR SALTS, THEIR PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE | |
| PL3305298T3 (pl) | Preparaty kwasu deoksycholowego i jego soli | |
| PL2702060T3 (pl) | Kwasowe addycyjne sole risperidonu i ich kompozycje farmaceutyczne | |
| ZA201207945B (en) | Salts of dexlansoprazole and their preparation | |
| EP2782902A4 (en) | DERIVATIVES FROM PHENOXYISOBUTTERIC ACID | |
| HUP1100272A2 (en) | Pharmaceutical use of silicic acid | |
| SG10201607013UA (en) | Formulations of deoxycholic acid and salts thereof | |
| TWI561526B (en) | Pharmaceutical composition of temozolomide comprising amino acid stabilizer and preparation method thereof |